主讲嘉宾：
Brian Cox, Ph.D.
Professor of Pharmaceutical Chemistry
University of Sussex
Brighton, UK
主讲嘉宾简介：Dr. Brian Cox received a BSc in Pharmacy and PhD from the University of Manchester. This was followed by postdoctoral study at the University and a two-year industrial postdoctoral training at Schering Plough in New Jersey. Dr. Cox then spent 12 years at GSK working in many different disease areas and developing a keen interest in the modulation of ion channels as a target class, where he is now a recognised expert. In 2002, he moved to Novartis and became head of chemistry with the site specialising in Respiratory and GI research. He is associated with a number of marketed compounds and multiple late stage clinical candidates. He is a champion of diversity and inclusion (D&I) serving on the Research D&I Council at Novartis for 5 years. In 2014, Dr. Cox joined the University of Sussex as a professor of pharmaceutical chemistry. Now he is also a Fellow of the Royal Pharmaceutical Society of Great Britain and registered pharmacist.
报告内容摘要：The talk describes two research programs including the discovery of novel CRTh2 receptor antagonists for treatment of allergic diseases and the discovery of CRF-1 antagonists for irritable bowel syndrome (IBS), which result in the identification of clinical candidates QAV680 and NVS-CRF38.
时间：2015年10月22日（周四）下午1:30
地点：复旦大学药学院科研楼西辅楼晶晖厅
